Suppr超能文献

普萘洛尔、阿普洛尔、索他洛尔、阿替洛尔和美托洛尔对甲状腺功能亢进患者血清T3和血清反T3的不同影响。

Different effects of propranolol, alprenolol, sotalol, atenolol and metoprolol on serum T3 and serum rT3 in hyperthyroidism.

作者信息

Perrild H, Hansen J M, Skovsted L, Christensen L K

出版信息

Clin Endocrinol (Oxf). 1983 Feb;18(2):139-42. doi: 10.1111/j.1365-2265.1983.tb03196.x.

Abstract

Serum T4, T3, rT3 and T3 resin uptake (T3 RU) were measured before and after 7 days of treatment with either propranolol, alprenolol, sotalol, atenolol or metoprolol in hyperthyroid patients. We found a significant decrease in serum T3 after propranolol, alprenolol, atenolol and metoprolol but no change in the sotalol treated group. A significant increase in rT3 was found in the propranolol and alprenolol treated groups whereas a significant fall in rT3 was found in the atenolol and metoprolol treated groups. No change was found in the sotalol treated group. The changes observed in serum T3 and in rT3 could be explained by an inhibition of the 5'deiodinase enzyme by propranolol and alprenolol and an inhibition of both the 5'deiodinase and 5 deiodinase enzymes caused by atenolol and metoprolol.

摘要

对甲状腺功能亢进患者在使用普萘洛尔、阿普洛尔、索他洛尔、阿替洛尔或美托洛尔治疗7天前后测定血清T4、T3、反T3(rT3)和T3树脂摄取率(T3 RU)。我们发现,使用普萘洛尔、阿普洛尔、阿替洛尔和美托洛尔后血清T3显著降低,但索他洛尔治疗组无变化。在普萘洛尔和阿普洛尔治疗组中rT3显著升高,而在阿替洛尔和美托洛尔治疗组中rT3显著下降。索他洛尔治疗组无变化。血清T3和rT3中观察到的变化可以用普萘洛尔和阿普洛尔对5′-脱碘酶的抑制作用以及阿替洛尔和美托洛尔对5′-脱碘酶和5-脱碘酶的抑制作用来解释。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验